![Pharmaceutics | Free Full-Text | In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers Pharmaceutics | Free Full-Text | In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-13-00556/article_deploy/html/images/pharmaceutics-13-00556-g001.png?1618488521)
Pharmaceutics | Free Full-Text | In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers
![Pharmaceutics | Free Full-Text | Comparison of Nozzle-Based and Nozzle-Free Electrospinning for Preparation of Fast-Dissolving Nanofibers Loaded with Ciprofloxacin Pharmaceutics | Free Full-Text | Comparison of Nozzle-Based and Nozzle-Free Electrospinning for Preparation of Fast-Dissolving Nanofibers Loaded with Ciprofloxacin](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-14-01559/article_deploy/html/images/pharmaceutics-14-01559-g011.png?1658974747)
Pharmaceutics | Free Full-Text | Comparison of Nozzle-Based and Nozzle-Free Electrospinning for Preparation of Fast-Dissolving Nanofibers Loaded with Ciprofloxacin
![Pharmaceutics | Free Full-Text | In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers Pharmaceutics | Free Full-Text | In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-13-00556/article_deploy/html/images/pharmaceutics-13-00556-g003.png?1618488521)
Pharmaceutics | Free Full-Text | In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers
![Frontiers | Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis Frontiers | Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis](https://www.frontiersin.org/files/MyHome%20Article%20Library/762307/762307_Thumb_400.jpg)
Frontiers | Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis
![Observational data from the adalimumab post‐marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis - Hart - 2022 - United European Gastroenterology Journal - Wiley Online Library Observational data from the adalimumab post‐marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis - Hart - 2022 - United European Gastroenterology Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1c4094ba-88f2-489f-8267-1ffe548d4952/ueg2.v10.5.cover.jpg?trick=1670023183842)
Observational data from the adalimumab post‐marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis - Hart - 2022 - United European Gastroenterology Journal - Wiley Online Library
![Exposure to antibiotics with anaerobic activity before respiratory viral infection is associated with respiratory disease progression after hematopoietic cell transplant | Bone Marrow Transplantation Exposure to antibiotics with anaerobic activity before respiratory viral infection is associated with respiratory disease progression after hematopoietic cell transplant | Bone Marrow Transplantation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41409-022-01790-8/MediaObjects/41409_2022_1790_Fig1_HTML.png)
Exposure to antibiotics with anaerobic activity before respiratory viral infection is associated with respiratory disease progression after hematopoietic cell transplant | Bone Marrow Transplantation
![Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development - Bialer - Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development - Bialer -](https://onlinelibrary.wiley.com/cms/asset/5af032f9-e47d-42b2-8203-478cde3b6468/epi.2018.59.issue-10.cover.jpg?trick=1677742128614)
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development - Bialer -
![Pharmaceutics | Free Full-Text | In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers Pharmaceutics | Free Full-Text | In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-13-00556/article_deploy/html/images/pharmaceutics-13-00556-g005.png?1618488521)
Pharmaceutics | Free Full-Text | In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers
![Frontiers | Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases Frontiers | Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases](https://www.frontiersin.org/files/Articles/946351/fphar-13-946351-HTML-r1/image_m/fphar-13-946351-g005.jpg)
Frontiers | Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
![A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis | Science Immunology A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.aaw2938/asset/729bbd23-6d19-4b6c-a19b-e429bc7856c4/assets/graphic/aaw2938-f1.jpeg)
A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis | Science Immunology
![Pulmonary & Nasal Drug Delivery - ONdrugDelivery - Issue 131 - April 2022 by ONdrugDelivery Magazine - Issuu Pulmonary & Nasal Drug Delivery - ONdrugDelivery - Issue 131 - April 2022 by ONdrugDelivery Magazine - Issuu](https://image.isu.pub/220410185601-5aa4512f7f67a6523db81a5378b3c44e/jpg/page_1.jpg)
Pulmonary & Nasal Drug Delivery - ONdrugDelivery - Issue 131 - April 2022 by ONdrugDelivery Magazine - Issuu
![Neuland Laboratories Limited - Transformation towards niche APIs? - Not-so-Hidden Gems - ValuePickr Forum Neuland Laboratories Limited - Transformation towards niche APIs? - Not-so-Hidden Gems - ValuePickr Forum](https://forum.valuepickr.com/uploads/default/original/3X/b/b/bb793227c46380519ec7c2a22bb48c6bbe51f979.jpeg)